US$ 20.55
bpc-157 human clinical trial safety review trials evidence regulatory status BPC‑157 — 10 mg bpc-157 human clinical trials evidence
Description
Pre-blended GLOW products are sold under the same research-only category

RecBCD, a helicase that initiates the SOS response, was inhibited, leading to DNA being damaged without an SOS response
Hepatoprotective effect of BPC 157, a 15-amino acid peptide, on liver lesions induced by either restraint stress or bile duct and hepatic artery ligation or CCl4 administration

Were committed to providing research-grade compounds that scientists can trust implicitly
